KALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME FOR PRODUCTION OF AN ADVANCED BEVERAGE INGREDIENT
Rapid success of first collaboration leads to partnership on high-value specialty ingredient Enzyme development expected to enable commercial-scale production in 2024 Kalamazoo, Michigan and Mountain View, California – May 23, 2023 – Willow Biosciences Inc. (“Willow“) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients and […]
WILLOW BIOSCIENCES ANNOUNCESANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS
Mountain View, California – May 12, 2023 – Willow Biosciences Inc.(“Willow” or the “Company“) (TSX: WLLW; OTCQB: CANSF) is pleased to announce the voting results from its annual general and special meeting of shareholders held on May 12, 2023 (the “Meeting“). A total of 57,318,575 common shares, representing approximately 46.329% of the Company’s issued and outstanding […]
WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2023 RESULTS
Starts off year with significant commercial momentum toward focus on delivering robust year-over-year revenue growth for 2023 Previous steps taken to further optimize Willow’s business, focus on near-term revenue generation and reduce cash burn are paying off Mountain View, California – May 11, 2023 – Willow Biosciences Inc.(“Willow” or the “Company“) (TSX: WLLW; OTCQB: CANSF), a […]
WILLOW ANNOUNCES COMMERCIAL AGREEMENT WITH SANDHILL ONE
Commercial agreement follows the early success on the development phase of the UDCA program with Sandhill One Solid execution on development phases leads to execution of agreement; illustrates company progress against targeted milestones anticipated for 2023 to expand company growth Willow’s unique combination of strain engineering, precision fermentation and its newly developed BioOxi™ bio-oxidation platform […]
WILLOW ANNOUNCES ROLLOUT OF BioOxi PLATFORM PROVIDING VALUABLE AND EXPEDITED BIOCONVERSION-ENABLED CHEMICAL MANUFACTURING
Complements Company’s significant expertise in existing strain engineering and precision fermentation Offers commercial partners more rapid product innovation at significantly reduced cost by removing multiple chemical steps in producing oxygenated and hydroxylated functional ingredients Creates additional business development opportunities and enables faster path to nearer-term revenue for Willow relative to legacy strain engineering applications Mountain […]
WILLOW BIOSCIENCES ANNOUNCES CHANGES TO BOARD AND MANAGEMENT
Willow Continues its Transition to the Bay Area in California with Management Promotions and a New Board Member Mountain View, California – March 28, 2023 – Willow Biosciences Inc.(“Willow” or the “Company“) (TSX: WLLW; OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable ingredients, is pleased to announce that […]